fianlimab,cemiplimab
sanofi,regeneron
['fianlimab', 'melanoma', 'cemiplimab', 'regeneron']
 presenting data at #asco2023 of the combination cemiplimab and fianlimab in poor prognosis melanomas. 
Oncologist @ The Angeles Clinic and Research Institute Cedars Sinai affiliate with phase 1 interest. Frmr phase 1 fellow at MD Anderson. KU Alum.